Oral administration of Lactobacillus paracasei alleviates clinical symptoms of colitis induced by dextran sulphate sodium salt in BALB/c mice

Beneficial Microbes

Volumn 5, Issue 3, 2014, Pages 315-322

  Pan, T ^a   Guo, H Y ^b   Zhang, H ^a   Liu, A P ^c   Wang, X X ^d   Ren, F Z ^a,b  

^a China Agricultural University   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c Inner Mongolia Mengniu Dairy (Group) Co Ltd   (China)

^d GANSU AGRICULTURAL UNIVERSITY   (China)

Author keywords

Animal model; DSS induced colitis; Lactobacillus paracasei; Pro inflammatory cytokine

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 1BETA; LACTOBACILLUS PARACASEID PROBIOTIC AGENT; MYELOPEROXIDASE; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL1B PROTEIN, MOUSE; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY SCORE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SYMPTOMATOLOGY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; CLASSIFICATION; COLON; DISEASE MODEL; FECES; INTESTINE MUCOSA; LACTOBACILLUS; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FECES; INFLAMMATION; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; LACTOBACILLUS; MALE; MICE; MICE, INBRED BALB C; PEROXIDASE; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904055780     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0041     Document Type: Article

References (40)

1. Bai, A.P. and Ouyang, Q., 2006. Probiotics and inflammatory bowel diseases. Postgraduate Medical Journal 82: 376-382.
2. Chen, L.L., Wang, X.H., Cui, Y., Lian, G.H., Zhang, J., Ouyang, C.H. and Lu, F.G., 2009. Therapeutic effects of four strains of probiotics on experimental colitis in mice. World Journal of Gastroenterology 15: 321-327.
3. Chen, X., Zhai, X., Shi, J., Liu, W.W., Tao, H., Sun, X. and Kang, Z., 2013. Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. Digestive Diseases and Sciences 58: 1560-1568.
4. Cho, E.J., Shin, J.S., Noh, Y.S., Cho, Y.W., Hong, S.J., Park, J.H., Lee, J.Y., Lee, J.Y. and Lee, K.T., 2011a. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis. Journal of Ethnopharmacology 136: 428-435.
5. Cho, J.Y., Chi, S.G. and Chun, H.S., 2011b. Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice. Molecular Nutrition and Food Research 55: 239-246.
6. Chung, Y.W., Choi, J.H., Oh, T.Y., Eun, C.S. and Han, D.S., 2008. Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice. Clinical and Experimental Immunology 151: 182-189.
7. Cooper, H.S., Murthy, S.N., Shah, R.S. and Sedergran, D.J., 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 69: 238-249.
8. De Palencia, P.F., López, P., Corbí, A.L., Peláez, C. and Requena, T., 2008. Probiotic strains: survival under simulated gastrointestinal conditions, in vitro adhesion to Caco-2 cells and effect on cytokine secretion. European Food Research and Technology 227: 1475-1484.
9. Di Sabatino, A., Biancheri, P., Rovedatti, L., MacDonald, T.T. and Corazza, G.R., 2012. Recent advances in understanding ulcerative colitis. Internal and Emergency Medicine 7: 103-111.
10. Geier, M.S., Butler, R.N., Giffard, P.M. and Howarth, G.S., 2007. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. International Journal of Food Microbiology 114: 267-274.
11. Hamamoto, N., Maemura, K., Hirata, I., Murano, M., Sasaki, S. and Katsu, K., 1999. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)). Clinical and Experimental Immunology 117: 462-468.
12. Herias, M.V., Koninkx, J.F.J.G., Vos, J.G. and Van Dijk, J.E., 2005. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. International Journal of Food Microbiology 103: 143-155.
13. Hirata, I., Yasumoto, S., Toshina, K., Inoue, T., Nishikawa, T., Murano, N., Wang, F.Y. and Katsu, K.I., 2007. Evaluation of the effect of pyrrolidine dithiocarbamate in suppressing inflammation in mice with dextran sodium sulfate-induced colitis. World Journal of Gastroenterology 13: 1666-1671.
14. Hur, S.J., Kang, S.H., Jung, H.S., Kim, S.C., Jeon, H.S., Kim, I.H. and Lee, J.D., 2012. Review of natural products actions on cytokine modulation in inflammatory bowel disease. Nutrition Research 32: 801-816.
15. Ishiguro, Y., 1999. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. Journal of Gastroenterology 34: 66-74.
16. Jakobovits, S.L., Jewell, D.P. and Travis, S.P.L., 2007. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Alimentary Pharmacology and Therapeutics 25: 1055-1060.
17. Kim, H.S., Chae, H.S., Jeong, S.G., Ham, J.S., Im, S.K., Ahn, C.N. and Lee, J.M., 2005. Antioxidant activity of some yogurt starter cultures. Asian-Australasian Journal of Animal Sciences 18: 255-258.
18. Kruidenier, L.A. and Verspaget, H.W., 2002. Oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Alimentary Pharmacology and Therapeutics 16: 1997-2015.
19. Kwon, K.H., Murakami, A., Tanaka, T. and Ohigashi, H., 2005. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochemical Pharmacology 69: 395-406.
20. Larrosa, M., González-Sarrías, A., Yáñez-Gascón, M.J., Selma, M.V., Azorín-Ortuño, M., Toti, S., Tomás-Barberán, F., Dolara, P. and Espín, J.C., 2010. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. The Journal of Nutritional Biochemistry 21: 717-725.
21. Lewis, J.D., Gelfand, J.M., Troxel, A.B., Forde, K.A., Newcomb, C., Kim, H., Margolis, D.J. and Strom, B.L., 2008. Immunosuppressant medications and mortality in inflammatory bowel disease. American Journal of Gastroenterology 103: 1428-1435.
22. Liu, Y., Su, Y.W., Ong, W.K., Cheng, T.H. and Tsai, Y.C., 2011. Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. International Immunopharmacology 11: 2159-2166.
23. Livak, K.J. and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
24. Matsuki, T., Watanabe, K., Fujimoto, J., Takada, T. and Tanaka, R, 2004. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Applied and Environmental Microbiology 70: 7220-7228.
25. Mileti, E., Matteoli, G., Iliev, I.D. and Rescigno, M., 2009. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE 4: e7056.
26. Nishitani, Y., Tanoue, T., Yamada, K., Ishida, T., Yoshida, M., Azuma, T. and Mizuno, M., 2009. Lactococcuslactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. International Immunopharmacology 9: 1444-1451.
27. Oz, H.S., Chen, T.S., McClain, C.J. and De Villiers, W.J., 2005. Antioxidants as novel therapy in a murine model of colitis. Journal of Nutritional Biochemistry 16: 297-304.
28. Pagnini, C., Delle Fave, G. and Bamias, G., 2013. Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications. World Journal of Immunology 3: 31-43.
29. Peran, L., Camuesco, D., Comalada, M., Bailon, E., Henriksson, A., Xaus, J., Zarzuelo, A. and Galvez, J., 2007. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. Journal of Applied Microbiology 103: 836-844.
30. Rachmilewitz, D., Karmeli, F., Shteingart, S., Lee, J., Takabayashi, K. and Raz, E., 2006. Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. Inflammatory Bowel Diseases 12: 339-345.
31. Regueiro, M., Curtis, J. and Plevy, S., 2006. Infliximab for hospitalized patients with severe ulcerative colitis. Journal of Clinical Gastroenterology 40: 476-481.
32. Sang, L.X., Chang, B., Zhang, W.L., Wu, X.M., Li, X.H. and Jiang, M., 2010. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World Journal of Gastroenterology 16: 1908-1915.
33. Schultz, J. and Kaminker, K., 1962. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Archives of Biochemistry and Biophysics 96: 465-467.
34. Şengül, N., Işi{dotless}k, S., Asli{dotless}m, B., Uçar, G. and Demirbaǧ, A.E., 2011. The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis. Digestive Diseases and Sciences 56: 707-714.
35. Shim, J.O., 2013. Gut microbiota in inflammatory bowel disease. Pediatric Gastroenterology, Hepatology and Nutrition 16: 17-21.
36. Sung, M.K. and Park, M.Y., 2013. Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view. World Journal of Gastroenterology 19: 994-1004.
37. Tabasco, R., Paarup, T., Janer, C., Peláez, C. and Requena, T., 2007. Selective enumeration and identification of mixed cultures of Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus, L. acidophilus, L. paracasei subsp. paracasei and Bifidobacterium lactis in fermented milk. International Dairy Journal 17: 1107-1114.
38. Watterlot, L., Rochat, T., Sokol, H., Cherbuy, C., Bouloufa, I., Lefèvre, F., Gratadoux, J.J., Honvo-Hueto, E., Chilmonczyk, S., Blugeon, S., Corthier, G., Langella, P. and Bermúdez-Humarán, L.G., 2010. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. International Journal of Food Microbiology 144: 35-41.
39. Yasui, Y., Hosokawa, M., Mikami, N., Miyashita, K. and Tanaka, T., 2011. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chemico-Biological Interactions 193: 79-87.
40. Zigra, P.I., Maipa, V.E. and Alamanos, Y.P., 2007. Probiotics and remission of ulcerative colitis: a systematic review. The Netherlands Journal of Medicine 65: 411-418.